|
1.
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar
|
|
2.
|
Gorlick R and Khanna C: Osteosarcoma. J
Bone Miner Res. 25:683–691. 2010. View
Article : Google Scholar
|
|
3.
|
Shimo T, Matsumura S, Ibaragi S, et al:
Specific inhibitor of MEK-mediated cross-talk between ERK and p38
MAPK during differentiation of human osteosarcoma cells. J Cell
Commun Signal. 1:103–111. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Luk F, Yu Y, Dong HT, Walsh WR and Yang
JL: New gene groups associated with dissimilar osteoblastic
differentiation are linked to osteosarcomagenesis. Cancer Genomics
Proteomics. 8:65–75. 2011.PubMed/NCBI
|
|
5.
|
Hruska KA, Mathew S and Saab G: Bone
morphogenetic proteins in vascular calcification. Circ Res.
97:105–114. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Barboza E, Caula A and Machado F:
Potential of recombinant human bone morphogenetic protein-2 in bone
regeneration. Implant Dent. 8:360–367. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Hay E, Lemonnier J, Fromigue O, Guenou H
and Marie PJ: Bone morphogenetic protein receptor IB signaling
mediates apoptosis independently of differentiation in osteoblastic
cells. J Biol Chem. 279:1650–1658. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Wrana JL: Regulation of Smad activity.
Cell. 100:189–192. 2000. View Article : Google Scholar
|
|
9.
|
Moustakas A and Heldin CH: Non-Smad
TGF-beta signals. J Cell Sci. 118:3573–3584. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Guicheux J, Lemonnier J, Ghayor C, Suzuki
A, Palmer G and Caverzasio J: Activation of p38 mitogen-activated
protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their
implication in the stimulation of osteoblastic cell
differentiation. J Bone Miner Res. 18:2060–2068. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Arnold SF, Tims E and McGrath BE:
Identification of bone morphogenetic proteins and their receptors
in human breast cancer cell lines: importance of BMP2. Cytokine.
11:1031–1037. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Hardwick JC, Van Den Brink GR, Bleuming
SA, et al: Bone morphogenetic protein 2 is expressed by and acts
upon, mature epithelial cells in the colon. Gastroenterology.
126:111–121. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Kleeff J, Maruyama H, Ishiwata T, et al:
Bone morphogenetic protein 2 exerts diverse effects on cell growth
in vitro and is expressed in human pancreatic cancer in vivo.
Gastroenterology. 116:1202–1216. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Soares AF, Xavier RL, da Costa Miguel MC,
de Souza LB and Pinto LP: Bone morphogenetic protein-2/4 and bone
morphogenetic protein receptor type IA expression in metastatic and
nonmetastatic oral squamous cell carcinoma. Am J Otolaryngol.
31:266–271. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Kim IY, Lee DH, Lee DK, et al: Decreased
expression of bone morphogenetic protein (BMP) receptor type II
correlates with insensitivity to BMP-6 in human renal cell
carcinoma cells. Clin Cancer Res. 9:6046–6051. 2003.PubMed/NCBI
|
|
16.
|
Katoh M and Terada M: Overexpression of
bone morphogenic protein (BMP)-4 mRNA in gastric cancer cell lines
of poorly differentiated type. J Gastroenterol. 31:137–139. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Langenfeld EM, Calvano SE, Abou-Nukta F,
Lowry SF, Amenta P and Langenfeld J: The mature bone morphogenetic
protein-2 is aberrantly expressed in non-small cell lung carcinomas
and stimulates tumor growth of A549 cells. Carcinogenesis.
24:1445–1454. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Langenfeld EM, Kong Y and Langenfeld J:
Bone morphogenetic protein 2 stimulation of tumor growth involves
the activation of Smad-1/5. Oncogene. 25:685–692. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Ide H, Yoshida T, Matsumoto N, et al:
Growth regulation of human prostate cancer cells by bone
morphogenetic protein-2. Cancer Res. 57:5022–5027. 1997.PubMed/NCBI
|
|
20.
|
Beck SE, Jung BH, Fiorino A, et al: Bone
morphogenetic protein signaling and growth suppression in colon
cancer. Am J Physiol Gastrointest Liver Physiol. 291:G135–G145.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Brubaker KD, Corey E, Brown LG and
Vessella RL: Bone morphogenetic protein signaling in prostate
cancer cell lines. J Cell Biochem. 91:151–160. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Ghosh-Choudhury N, Woodruff K, Qi W,
Celeste A, Abboud SL and Ghosh Choudhury G: Bone morphogenetic
protein-2 blocks MDA MB 231 human breast cancer cell proliferation
by inhibiting cyclin-dependent kinase-mediated retinoblastoma
protein phosphorylation. Biochem Biophys Res Commun. 272:705–711.
2000. View Article : Google Scholar
|
|
23.
|
Kawamura C, Kizaki M, Yamato K, et al:
Bone morphogenetic protein-2 induces apoptosis in human myeloma
cells with modulation of STAT3. Blood. 96:2005–2011.
2000.PubMed/NCBI
|
|
24.
|
Wen XZ, Miyake S, Akiyama Y and Yuasa Y:
BMP-2 modulates the proliferation and differentiation of normal and
cancerous gastric cells. Biochem Biophys Res Commun. 316:100–106.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Wang L, Park P, Zhang H, et al: BMP-2
inhibits the tumorigenicity of cancer stem cells in human
osteosarcoma OS99-1 cell line. Cancer Biol Ther. 11:457–463. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Wang L, Park P, Zhang H, et al: BMP-2
inhibits tumor growth of human renal cell carcinoma and induces
bone formation. Int J Cancer. 131:1941–1950. 2012. View Article : Google Scholar
|
|
27.
|
Gillette JM, Gibbs CP and Nielsen-Preiss
SM: Establishment and characterization of OS 99-1, a cell line
derived from a highly aggressive primary human osteosarcoma. In
Vitro Cell Dev Biol Anim. 44:87–95. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Wang L, Park P, Zhang H, La Marca F and
Lin CY: Prospective identification of tumorigenic osteosarcoma
cancer stem cells in OS99-1 cells based on high aldehyde
dehydrogenase activity. Int J Cancer. 128:294–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Eguchi Y, Wakitani S, Imai Y, et al:
Antitumor necrotic factor agent promotes BMP-2-induced ectopic bone
formation. J Bone Miner Metab. 28:157–164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Luo X, Chen J, Song WX, et al: Osteogenic
BMPs promote tumor growth of human osteosarcomas that harbor
differentiation defects. Lab Invest. 88:1264–1277. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Le Page C, Puiffe ML, Meunier L, et al:
BMP-2 signaling in ovarian cancer and its association with poor
prognosis. J Ovarian Res. 2:42009.PubMed/NCBI
|
|
32.
|
Kuo PL, Hsu YL, Chang CH and Chang JK:
Osthole-mediated cell differentiation through bone morphogenetic
protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway
in human osteoblast cells. J Pharmacol Exp Ther. 314:1290–1299.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Mirabello L, Troisi RJ and Savage SA:
International osteosarcoma incidence patterns in children and
adolescents, middle ages and elderly persons. Int J Cancer.
125:229–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Tang N, Song WX, Luo J, Haydon RC and He
TC: Osteosarcoma development and stem cell differentiation. Clin
Orthop Relat Res. 466:2114–2130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Wozney JM, Rosen V, Celeste AJ, et al:
Novel regulators of bone formation: molecular clones and
activities. Science. 242:1528–1534. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Katsuno Y, Hanyu A, Kanda H, et al: Bone
morphogenetic protein signaling enhances invasion and bone
metastasis of breast cancer cells through Smad pathway. Oncogene.
27:6322–6333. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Piccirillo SG, Reynolds BA, Zanetti N, et
al: Bone morphogenetic proteins inhibit the tumorigenic potential
of human brain tumour-initiating cells. Nature. 444:761–765. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Nozaki K, Kadosawa T, Nishimura R,
Mochizuki M, Takahashi K and Sasaki N: 1,25-Dihydroxyvitamin D3,
recombinant human transforming growth factor-beta 1 and recombinant
human bone morphogenetic protein-2 induce in vitro differentiation
of canine osteosarcoma cells. J Vet Med Sci. 61:649–656. 1999.
View Article : Google Scholar
|
|
39.
|
Orui H, Imaizumi S, Ogino T and Motoyama
T: Effects of bone morphogenetic protein-2 on human tumor cell
growth and differentiation: a preliminary report. J Orthop Sci.
5:600–604. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Ma Y, Ma L, Guo Q and Zhang S: Expression
of bone morphogenetic protein-2 and its receptors in epithelial
ovarian cancer and their influence on the prognosis of ovarian
cancer patients. J Exp Clin Cancer Res. 29:852010. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Hall AK and Miller RH: Emerging roles for
bone morphogenetic proteins in central nervous system glial
biology. J Neurosci Res. 76:1–8. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Lee J, Son MJ, Woolard K, et al:
Epigenetic-mediated dysfunction of the bone morphogenetic protein
pathway inhibits differentiation of glioblastoma-initiating cells.
Cancer Cell. 13:69–80. 2008. View Article : Google Scholar
|
|
43.
|
Yamate J, Kotera T, Kuwamura M and Kotani
T: Potential osteogenic differentiation of cisplatin-resistant rat
malignant fibrous histiocytoma-derived cell lines. Exp Toxicol
Pathol. 58:299–309. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Reddi AH: Bone morphogenetic proteins:
from basic science to clinical applications. J Bone Joint Surg Am.
83-A(Suppl 1): S1–S6. 2001.PubMed/NCBI
|
|
45.
|
Ulsamer A, Ortuno MJ, Ruiz S, et al: BMP-2
induces Osterix expression through up-regulation of Dlx5 and its
phosphorylation by p38. J Biol Chem. 283:3816–3826. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Nakashima K, Zhou X, Kunkel G, et al: The
novel zinc finger-containing transcription factor osterix is
required for osteoblast differentiation and bone formation. Cell.
108:17–29. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
zur Nieden NI, Kempka G and Ahr HJ: In
vitro differentiation of embryonic stem cells into mineralized
osteoblasts. Differentiation. 71:18–27. 2003.PubMed/NCBI
|
|
48.
|
Nohe A, Keating E, Knaus P and Petersen
NO: Signal transduction of bone morphogenetic protein receptors.
Cell Signal. 16:291–299. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Fong S, Chan MK, Fong A, Bowers WJ and
Kelly KJ: Viral vector-induced expression of bone morphogenetic
protein 2 produces inhibition of tumor growth and bone
differentiation of stem cells. Cancer Gene Ther. 17:80–85. 2010.
View Article : Google Scholar : PubMed/NCBI
|
